ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/07 | 1,805 | 1,823 | 1,752 | 1,804 | +15 | +0.8% | 172,500 |
2021/06/04 | 1,783 | 1,799 | 1,762 | 1,789 | -13 | -0.7% | 134,200 |
2021/06/03 | 1,756 | 1,806 | 1,742 | 1,802 | +52 | +3% | 255,100 |
2021/06/02 | 1,740 | 1,772 | 1,732 | 1,750 | +5 | +0.3% | 221,600 |
2021/06/01 | 1,656 | 1,748 | 1,652 | 1,745 | +75 | +4.5% | 309,400 |
2021/05/31 | 1,592 | 1,673 | 1,587 | 1,670 | +78 | +4.9% | 281,800 |
2021/05/28 | 1,565 | 1,594 | 1,552 | 1,592 | +37 | +2.4% | 98,600 |
2021/05/27 | 1,555 | 1,574 | 1,545 | 1,555 | -18 | -1.1% | 112,700 |
2021/05/26 | 1,541 | 1,586 | 1,527 | 1,573 | +27 | +1.7% | 127,900 |
2021/05/25 | 1,573 | 1,579 | 1,543 | 1,546 | -32 | -2% | 81,600 |
2021/05/24 | 1,598 | 1,598 | 1,563 | 1,578 | -42 | -2.6% | 99,400 |
2021/05/21 | 1,575 | 1,631 | 1,568 | 1,620 | +75 | +4.9% | 134,200 |
2021/05/20 | 1,520 | 1,560 | 1,511 | 1,545 | +32 | +2.1% | 100,100 |
2021/05/19 | 1,483 | 1,520 | 1,469 | 1,513 | +18 | +1.2% | 131,600 |
2021/05/18 | 1,521 | 1,521 | 1,485 | 1,495 | -28 | -1.8% | 223,100 |
2021/05/17 | 1,605 | 1,614 | 1,489 | 1,523 | -70 | -4.4% | 288,900 |
2021/05/14 | 1,592 | 1,608 | 1,572 | 1,593 | +13 | +0.8% | 74,100 |
2021/05/13 | 1,576 | 1,605 | 1,563 | 1,580 | -9 | -0.6% | 99,100 |
2021/05/12 | 1,619 | 1,629 | 1,565 | 1,589 | -30 | -1.9% | 150,900 |
2021/05/11 | 1,598 | 1,654 | 1,598 | 1,619 | +12 | +0.7% | 127,000 |
2021/05/10 | 1,610 | 1,619 | 1,599 | 1,607 | +8 | +0.5% | 96,800 |
2021/05/07 | 1,618 | 1,622 | 1,591 | 1,599 | -14 | -0.9% | 84,800 |
2021/05/06 | 1,651 | 1,661 | 1,611 | 1,613 | -38 | -2.3% | 81,400 |
2021/04/30 | 1,698 | 1,701 | 1,648 | 1,651 | -48 | -2.8% | 80,300 |
2021/04/28 | 1,691 | 1,717 | 1,661 | 1,699 | +20 | +1.2% | 127,100 |
2021/04/27 | 1,674 | 1,692 | 1,656 | 1,679 | +23 | +1.4% | 137,200 |
2021/04/26 | 1,619 | 1,661 | 1,605 | 1,656 | +44 | +2.7% | 109,700 |
2021/04/23 | 1,644 | 1,675 | 1,610 | 1,612 | -32 | -1.9% | 141,600 |
2021/04/22 | 1,617 | 1,656 | 1,617 | 1,644 | +27 | +1.7% | 82,700 |
2021/04/21 | 1,590 | 1,646 | 1,583 | 1,617 | +12 | +0.7% | 144,300 |
2021/04/20 | 1,630 | 1,635 | 1,603 | 1,605 | -35 | -2.1% | 132,100 |
2021/04/19 | 1,644 | 1,660 | 1,628 | 1,640 | -14 | -0.8% | 68,600 |
2021/04/16 | 1,639 | 1,655 | 1,613 | 1,654 | +41 | +2.5% | 113,900 |
2021/04/15 | 1,567 | 1,617 | 1,554 | 1,613 | +46 | +2.9% | 124,700 |
2021/04/14 | 1,569 | 1,579 | 1,561 | 1,567 | -5 | -0.3% | 99,200 |
2021/04/13 | 1,586 | 1,589 | 1,561 | 1,572 | -25 | -1.6% | 143,700 |
2021/04/12 | 1,640 | 1,640 | 1,593 | 1,597 | -48 | -2.9% | 138,500 |
2021/04/09 | 1,657 | 1,670 | 1,636 | 1,645 | -5 | -0.3% | 109,300 |
2021/04/08 | 1,680 | 1,680 | 1,626 | 1,650 | -37 | -2.2% | 123,700 |
2021/04/07 | 1,685 | 1,691 | 1,648 | 1,687 | -3 | -0.2% | 161,300 |
2021/04/06 | 1,732 | 1,739 | 1,664 | 1,690 | -40 | -2.3% | 147,000 |
2021/04/05 | 1,782 | 1,783 | 1,724 | 1,730 | -52 | -2.9% | 153,700 |
2021/04/02 | 1,792 | 1,810 | 1,756 | 1,782 | +3 | +0.2% | 262,500 |
2021/04/01 | 1,707 | 1,817 | 1,707 | 1,779 | +110 | +6.6% | 652,800 |
2021/03/31 | 1,640 | 1,678 | 1,633 | 1,669 | +20 | +1.2% | 138,200 |
2021/03/30 | 1,606 | 1,660 | 1,606 | 1,649 | +32 | +2% | 176,700 |
2021/03/29 | 1,680 | 1,680 | 1,604 | 1,617 | -49 | -2.9% | 172,000 |
2021/03/26 | 1,638 | 1,675 | 1,632 | 1,666 | +38 | +2.3% | 164,500 |
2021/03/25 | 1,612 | 1,638 | 1,587 | 1,628 | +28 | +1.8% | 156,100 |
2021/03/24 | 1,601 | 1,621 | 1,569 | 1,600 | -12 | -0.7% | 165,000 |
851~
900
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
Chordia | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム